Original ArticleSeizures and Outcome One Year After Neonatal and Childhood Cerebral Sinovenous Thrombosis
Introduction
Cerebral sinovenous thrombosis (CSVT) is an uncommon but serious cause of acute brain injury, acute symptomatic seizures, and remote epilepsy in children. In the large adult International Study on Cerebral Vein and Dural Sinus Thrombosis, nearly 40% experienced seizures at or before diagnosis.1 Seizures are also reported as a common presenting sign in pediatric CSVT case series and registry data,2, 3, 4, 5 but prospective studies of seizures after neonatal and childhood CSVT have been limited and few studies report epilepsy and neurological outcomes beyond discharge.6 In a retrospective Northern California pediatric stroke cohort that included children with arterial ischemic stroke and CSVT, approximately one-quarter of children with an infarct due to CSVT developed epilepsy by two years after stroke and epilepsy incidence rates were similar in patients with arterial or venous infarcts.7 In prior series, 8% to 38% pediatric patients with CSVT have developed epilepsy after variable lengths of follow-up,2,8,9 suggesting that epilepsy is a frequent sequela. However, prospective, systematically collected data regarding epilepsy frequency and severity after pediatric CSVT are lacking.
Our objective was to prospectively study the outcome of neonates and children one year after a CSVT diagnosis, including epilepsy and standardized scoring of neurological disability. In this descriptive article we report on epilepsy and developmental outcomes in neonates and children who present with acute symptomatic seizures at the time of their CSVT diagnosis.
Section snippets
Methods
The Seizures in Pediatric Stroke (SIPS) Study was a prospective cohort study that enrolled term neonates (birth at ≥ 37 weeks' gestational age to 28 days of life) and children (29 days to 18 years of life) with arterial ischemic stroke or CSVT from 21 international sites between June 2011 and December 2012 as previously described.10,11 All sites obtained informed consent from guardians and study approval from local institutional review boards. Only participants with CSVT were included in this
Results
We identified 24 patients with CSVT from a total of 142 with ischemic stroke enrolled in the SIPS study10 (Fig). Sixteen (67%) were male and five (21%) were neonates. Headache was the most common clinical presentation in non-neonates with CSVT (47%, nine of 19 children). The most common risk factor for childhood CSVT was a chronic disorder, identified in 42% (10 of 24). These included suspected or confirmed genetic syndromes and chronic hematologic conditions or malignancies. Baseline
Discussion
In this prospective study of 24 pediatric patients diagnosed with CSVT, a quarter of patients were diagnosed with epilepsy by 12-month follow-up. This is consistent with previous reported prevalence of epilepsy after CSVT of 8% to 38%.2,7, 8, 9 Previous studies in patients with arterial ischemic stroke demonstrated that those with acute seizures at onset of stroke are at higher risk of developing epilepsy.7,18 Prolonged and recurrent seizures in the acute period also predict increased epilepsy
References (27)
- et al.
Radiological and clinical features of cerebral sinovenous thrombosis in newborns and older children
J Neuroradiol
(2016) - et al.
Risk factors for remote seizure development in patients with cerebral vein and dural sinus thrombosis
Seizure
(2014) - et al.
Neonatal sinovenous thrombosis: presentation and association with imaging
Pediatr Neurol
(2008) - et al.
Early seizures in cerebral vein and dural sinus thrombosis
Stroke
(2008) - et al.
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome
Brain
(2005) - et al.
Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study
Thromb Haemost
(2004) - et al.
Paediatric cerebral sinovenous thrombosis: findings of the international paediatric stroke study
Arch Dis Child
(2015) Cerebral sinovenous thrombosis
Front Pediatr
(2017)- et al.
Acute seizures predict epilepsy after childhood stroke
Ann Neurol
(2013) - et al.
Cerebral sinus venous thrombosis in Swiss children
Dev Med Child Neurol
(2010)
A prospective outcome study of neonatal cerebral sinovenous thrombosis
J Child Neurol
Prolonged or recurrent acute seizures after pediatric arterial ischemic stroke are associated with increasing epilepsy risk
Dev Med Child Neurol
Children with post-stroke epilepsy have poorer outcomes one year after stroke
Int J Stroke
Cited by (19)
Pediatric Cerebral Sinovenous Thrombosis and Risk for Epilepsy
2023, Pediatric NeurologySeizures in Pediatric Moyamoya: Risk Factors and Functional Outcomes
2023, Pediatric NeurologyCerebral Sinovenous Thrombosis in Infants and Children: A Practical Approach to Management
2022, Seminars in Pediatric NeurologyCitation Excerpt :Although infrequently attributable to the CSVT, mortality is reported, particularly if associated with ICH.1,- –7,11,12,14-19,28,43,44,75 Most cohorts, pediatric and neonatal, show that approximately 1/3-2/3 of children have some neurological abnormality at discharge from hospital and long term (when data was available).1,3-6,9-12,14-19,43,44,75-78 It is however unclear if anticoagulants directly improve long-term clinical outcomes.
Neurological and Functional Outcomes after Pediatric Stroke
2022, Seminars in Pediatric NeurologyCitation Excerpt :Predictors of poorer cognitive outcomes include the presence of neurological comorbidities,20,96,98,105 male sex,20,105 older age at CSVT,20 and a need for rehabilitation after stroke.20 Symptomatic seizures are a common presentation for pediatric CSVT, and the rates of subsequent epilepsy are between 18%-25%, significantly higher than the risk of epilepsy in the general population.98,99 Lack of symptomatic seizures during acute pediatric CSVT does not preclude development of epilepsy.99
Disclaimers: The authors declare no potential conflict of interest with respect to research, authorship, and/or publication of this article.
Sources of support: Pediatric Epilepsy Research Foundation (grant 112010-007), Auxilium Foundation, National Institutes of Health (2K12NS001692-11 and KL2TR000143).
- ∗∗
See Appendix I for Seizures in Pediatric Stroke (SIPS) sites and investigators.